Tata Elxsi Ltd
NSE:TATAELXSI
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
6 383
8 950.1
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Tata Elxsi Ltd
Earnings Call Analysis
Q2-2025 Analysis
Tata Elxsi Ltd
In the second quarter of FY 2024/25, Tata Elxsi reported steady growth, with total revenues from operations reaching INR 955.1 crores, reflecting a quarter-on-quarter increase of 3.1%. However, in constant currency terms, revenues experienced only a modest growth of 0.2%. This indicates that while the company is expanding, external factors may be influencing growth rates.
The Transportation sector emerged as the primary contributor to Tata Elxsi's growth, recording a 4.4% increase in constant currency terms. The company secured a landmark USD 50 million multiyear deal with a global OEM in Europe, enhancing its position in the automotive engineering sector. This deal focuses on software-defined vehicles (SDVs) and positions Tata Elxsi well within the transformative automotive landscape.
Conversely, the Media and Communication segment faced a 2.2% decline quarter-on-quarter due to delays in customer decisions and project completions. The management anticipates a potential rebound, noting improvements in network transformation and AI innovations that could revitalize this slowly recovering vertical.
The Healthcare and Life Sciences segment saw a significant downturn, reporting an 11.2% decline since the previous quarter. Delays in project renewals were predominantly responsible for this decline. However, management is optimistic about recovery, indicating that strong customer relationships may lead to new project starts, with expectations of improvement in the coming quarters.
Tata Elxsi improved its EBITDA margins by 70 basis points to 27.9%, with profit after tax rising 24.6% to INR 229.4 crores, aided by favorable R&D incentives and tax credits. This improved profitability comes despite the challenges faced in certain sectors, indicating strong operational efficiency and fiscal discipline.
The company highlighted the increased contribution from various markets, with revenues from India growing by 31.2% year-on-year and Japan and emerging markets expanding by 81.9% year-on-year. This geographical diversification helps cushion against potential downturns in more saturated markets.
Looking forward, Tata Elxsi’s management remains cautiously optimistic about sustaining growth momentum. They aim for double-digit growth in constant currency for FY '25, a challenging but achievable target, depending on the ramp-up of existing projects and the successful acquisition of new contracts. Management emphasized the importance of large deals, suggesting that even securing one or two significant contracts each quarter could support overall growth.
The company reported a controlled attrition rate of 12.5% and highlighted utilization rates at around 69.5%. A cautious approach to hiring is being maintained, reflecting a strategic pivot to ensure sustained growth without overextending resources, especially in less predictable segments such as Healthcare and Media.
Tata Elxsi is also exploring potential new verticals, especially in defense and semiconductors. The management acknowledged the need to adapt capabilities to seize opportunities in these high-tech sectors, focusing on the ideals of capturing future growth and mitigating cyclicality in existing markets.
Despite various headwinds from global economic pressures, such as job loss data in major markets, Tata Elxsi's offshore delivery model is expected to provide a buffer against these fluctuations. The management expressed confidence in their approach to maintain operational integrity and customer engagement, positioning the firm to thrive regardless of market cycles.
You don't have any saved screeners yet
Ladies and gentlemen, good day, and welcome to the Tata Elxsi Q2 FY '24/'25 Earnings Conference Call. [Operator Instructions] Please note that this conference is being recorded. I now hand the conference over to Mr. Shashank Ganesh from E&Y. Thank you, and over to you, sir.
Thank you very much. Good evening to all the participants on the call. Good morning for joining us from the Western side. Before we proceed to the call, let me remind you that the discussion may contain forward-looking statements that may involve known or unknown risks, uncertainties and other factors. Therefore, it must be viewed in conjunction with the business risk that would cause further result performance or achievements that differ significantly from what is expressed or implied by such forward-looking statements.
To take us through the results and answer your questions today, we have the senior management of Tata Elxsi, represented by Mr. Manoj Raghavan, Managing Director and CEO; Mr. Nitin Pai, Chief Marketing and Chief Strategy Officer; Mr. Gaurav Bajaj, Chief Financial Officer; and Ms. Cauveri Sriram, Company Secretary. We will start the call with a brief overview of the past quarter by Mr. Raghavan, followed by a Q&A session. We would appreciate your cooperation in restricting yourself to 2 questions to allow participants a chance to interact. If you have any further questions, you may join the queue, and we will be happy to respond to them if time permits. With that, I would like to hand over the call to Mr. Manoj Raghavan. Over to you, Manoj.
Thank you, Shashank. Good evening, everyone. Thank you for joining us today for our quarter 2 FY '25 Investor Call. Before we start discussing about the quarter 2 performance of the company, I'd like to take a moment to share the profound loss that the Tata Elxsi family feels in our hearts on losing Mr. Ratan Tata. He played a pivotal role in the founding of this company and had always encouraged the technology, innovation and design-led business approach that Tata Elxsi is now well known for. His memory will forever remain in our hearts, and his vision and legacy will continue to shape our future.
Coming to our second quarter performance, we are pleased to report a steady quarter with revenues from operations growing to INR 955.1 crores, registering a quarter-on-quarter growth of 3.1%. In constant currency terms, the operating revenues stayed flat, registering a modest growth of 0.2% quarter-on-quarter.
Our Transportation business continues to power the growth for the company, registering a healthy revenue growth of 4.4% quarter-on-quarter in constant currency terms. Our strong ADAS connected, electric and software defined vehicle capabilities are helping us win large deals with global OEMs across the world, positioning us well for the continued transformation of the automotive industry. We won a landmark USD 50 million multiyear deal from a global OEM headquartered in Europe, which encompasses SDV and multiple domains of automotive engineering. This strategic engagement will enable SDV platform development and the next generation of mobility for this world-leading brand.
During the quarter, we also announced a strategic engagement with Nidec Corporation, Japan, to support their group technology initiatives, especially for the automotive market. We also launched a global Next-gen Mobility Innovation center in Bangalore in partnerships with Emerson.
Our Media and Communication business declined by 2.2% quarter-on-quarter in constant currency terms, largely because of pending customer decisions and some large deals that we have been pitching for, and also natural completion of some of the projects that we have been working over the last several quarters. That said, we see green shoots for growth led by our network transformation offerings and the digital Gen AI led innovation for the future of media.
I'm especially delighted with our world's first RDK Broadband implementation for Qualcomm, which allows global telecom operators to adopt this first-of-its kind solution to deliver high-speed home and enterprise broadband services with a 5G network. We also won a strategic AI Center of Excellence deal with a leading Middle East operator, which will support their company-wide transformation initiatives, including reimagining products, customer experience, operations, customer support and software development.
Healthcare and Life Sciences business reported a decline in top line by 11.2% quarter-on-quarter in constant currency terms. This is due to delay in renewal and start of some new programs with our leading U.S.-based customer. We have added some new customers, including a global renal care leader and a U.S. headquartered healthtech AI leader, which should scale over the next few quarters.
Skanray, a leading global MedTech R&D and manufacturing company, specializing in diagnostic imaging, critical care and surgery/OT solutions, has chosen Tata Elxsi as a strategic partner for advanced surgical imaging core technology and software platform development. This underscores our unique ability to bring together design, cloud and AI to reimagine health care diagnostics and patient care.
Also, we launched a state-of-the-art robotics innovation lab in Frankfurt in partnership with Denso Robotics and AATech designed to revolutionize automation and robotics for various sectors, including precision surgery and health care. We are witnessing an unprecedented convergence of design software and digital technologies such as AI and how enterprises are reimagining their product services and customer experience. With our strong AI capabilities and design-digital capabilities, we are well positioned to demonstrate and create value, win new customers and engage deeper with our global customer base.
Our operational and also delivery excellence, fiscal discipline and differentiated offerings have contributed to our EBITDA margins expanding by 70 basis points to 27.9% for the quarter. Our PAT grew by 24.6% quarter-on-quarter to INR 229.4 crores, with a superior bottom line performance further aided by R&D incentives and tax credits from previous years.
Our strategic focus on expanding our business in Japan, emerging markets and capitalizing on the India opportunity is now starting to significantly contribute to our growth. During the quarter, our revenues from India grew by 31.2% year-on-year, while Japan and emerging markets grew smartly at 81.9% year-on-year.
On the people front, at 12.5%, our attrition remains under control as we prepare to onboard the next batch of freshers. We step into the third quarter of the financial year with the confidence of a healthy deal pipeline, continued growth in our transportation business, large deal wins and a recovery in our other key verticals. I now open the floor for questions.
[Operator Instructions] Our first question is from the line of Bhavik Mehta from JPMorgan.
So a couple of questions. Firstly, on the transportation vertical, we have seen obviously very strong growth in the last 2 quarters. But given where the environment is a lot of global OEMs are cutting back on EV target, and given your deal pipeline and the deals already closed, how should we think about the growth in this vertical over the next couple of quarters going ahead?
Yes. What you say is true. In general, the automotive industry, we see a lot of news out there. So the good part for us is there are deals that we have built and there are deals that we have won that we have to execute and ramp up. So while there is a sort of slowdown or softness in the automotive market generally, but I think as far as Tata Elxsi is concerned, because of some of the deal wins that we've had that we will ramp up and some of the deals that we have already bid for, we are still hopeful that we will have a decent growth in H2.
Okay. Okay. Got it. That's helpful. Secondly, on the healthcare side, are the headwinds from the U.S. and all behind now? And do we see growth coming back from 3Q? Or will it take some more time before this vertical comes back on the growth mode?
I strongly believe that we have bottomed out. I mean, even in our Q1, we did indicate that we have this softness in the market. We believe we have bottomed out in Q2 and Q3, we should see a growth. Again, there are good conversations happening with customers, and the one-off customer, pretty large customer of us that we've sort of -- there is some delayed decision we hope that we will recover in Q3.
Okay. Got it. And just lastly, can you provide margin walk for this quarter?
I will ask Gaurav to take that question.
So our operating margin expanded by 70 basis points sequentially compared to the quarter 1. The major ups and downs for the margin walk, I think we have a cross-currency benefit of 160 basis point. Most of the major currencies move favorably for us in this quarter. Our other expenses came down substantially during this quarter compared to the last quarter. Last quarter, we had onetime contribution. That has brought almost 130-basis-point uptick into the margins at the operating level. We also mentioned last quarter that we would be doing the junior to mid-level salary hikes that we have done effective 1st July. That has an impact of 120 basis point. And our cost of other goods, which entails some of the lab setups, tools and other hardware that is required for some of the larger program starting during the quarter, that has an impact of 100 basis points. So that sums up to 70-basis-point increase in our operating margin on a quarter-to-quarter basis.
[Operator Instructions] Our next question is from the line of Sukant Garg from Equible Research Private Limited.
So I have 2 questions here. One is related to the healthcare segment. Is there any loss of customer in case of our renewals in the healthcare segment?
No, there is no loss of customer. We have had delays in the -- we have execution of -- sorry, not execution, delay in start of new programs with existing customers.
Okay. And my next question is with regards to the Transportation sector. So as we see the last quarter, the Transportation sector has been growing pretty well, and this quarter as well, it has been [Foreign Language] there is a good growth. So how do you see this sector in the next H2 or the next year FY '26. Is that the same level of growth that we're going to achieve or is it going to be subside down?
It's very difficult to talk about FY '26 given the dynamics that is happening in the industry and the trends that we are seeing, right? But however, as I explained in the previous question, which Bhavik has asked, the H2 for us, we are pretty confident because of the deals that we have already won and the ramp-ups that we have to do, right? And also some of the new deals that we are -- that we have placed in the last quarter, and ongoing deals that we are chasing this quarter also. So we see a good deal pipeline. And I believe we can continue the growth in H2.
So do we also see a consolidation at headcount level? Or is it going to be bottomed out now, and we're going to increase the head count from now on?
Yes, you're talking about headcount?
Yes, yes.
Yes. So we will be very cautious in adding headcount. And so we have a very, very strict -- we will only add headcount where there is any specialized skills that we don't have to execute the projects that we have won, right? So having said that, we will add the freshers from the universities that we have hired for during the campus last year, they will start coming in, in Q3 and Q4.
Is it majorly because of the consolidation of the projects that headcount has not been happening or there are only existing projects that's been going on due to which the head count is stagnant?
No. So the head count, we have seen a drop in the headcount because we have stopped aggressively hiring. We used to hire anywhere between 500, 600 resources every quarter. That has dropped now this quarter. So we have taken a very, very careful view of adding more headcount at this point in time, which is from a lateral point of view, right? And -- but having said that, from a fresher hiring perspective, we will continue to hire fresher in the H2.
No, I mean to say that if we are adding new projects and if we are not adding the headcount, so what you want to say is the head count that we have currently is...
Yes, yes. We have billability, we have a utilization of around 69.5%. So we have enough headroom to manage the new projects with the headcount that is already available internally. We will still go ahead and hire only certain critical resources that we need to execute very specific projects and so on.
[Operator Instructions] The next question is from the line of Salil Desai from Marcellus Investment Managers.
On the previous question, I want to kind of understand that a little better. The whole of last year or almost about 5 or 6 quarters now, we have added net headcount. And this quarter, still you're turning cautious. So is there any change in the way you're looking at the outlook for the last year's hiring pipeline kind of more than sufficient versus what growth expectations actually how they panned out. How should one reconcile the change in view on headcount additions versus growth?
We have a healthy bench, right, at this point in time. Our utilization is only about 69%, 69.5%. So given the overall status that we have in two of our major businesses, right, Media and Communication as well as the Healthcare and Life Sciences, we are a little cautious in adding more resources in those businesses. However, from a Transportation and the Industrial Design business that we have, we are ramping up headcount and resources. So if you look at our overall level, we -- you might see a flattening or you might even see a dip in the headcount, but that is also because the last financial year, in Q2, we have added freshers. We started the freshers hiring in Q2 itself. This financial year, we have pushed that to Q3.
Okay. Okay. All right. And in case, how would you like to comment on how the overall supply side situation is? So if tomorrow in Healthcare things change and if you were to ramp up, what are the chances that could be constraint on finding the right people?
No. I think at this point in time, people is not a big challenge for the industry. So I think that's not going to be an issue given at this point in time. We can never know after 2 quarters what is the situation. But I think for the next 2 quarters, people -- I mean the supply side should not be an issue.
The next question is from the line of Moez Chandani from Ambit.
My first question was you previously said that you expected to close FY '25 at a better growth rate than FY '24. I want to check if that's still something that you expect to do for this financial year?
That's a very difficult question to answer at this point in time. If we had -- if the Q2 performance was a notch better, we would have still been confident. We are -- though we have a visibility and so on, the industry cycles are so unpredictable nowadays and what we hope to close -- the deals that we are going after, we hope to close in 3 months is now getting pushed to 6 months and so on, right? So there is a general slowness in the market. But having said that, we still hope to show superior growth in H2 to return back to our -- the growth that used to happen maybe 4 quarters ago or 6 quarters ago. So at this point in time, I would say, our target is definitely to go after -- end the year with a double-digit constant currency growth.
I know it is asking too much and it is tough. But what really -- why I'm a little confident is the sort of deals that we're pursuing and sort of pipeline that we are seeing. We could -- we definitely want to -- don't want to lower our goals. We still want to go after that double-digit growth, and we'll put in all our best to see whether we can reach there.
How has growth been with our top client versus growth across the rest of the auto OEMs? And are we still seeing pressure on Tier 1 suppliers versus the auto OEMs that we have noted previously?
So yes, I think auto OEMs are definitely growing faster than the Tier 1, which is positive. So I think not just the top customer, OEM customer that we have, the other OEM customers have also shown growth in the quarter. The Tier 1s, I think only a few Tier 1s, I could say, are showing that growth. A lot of other Tier 1s are either remaining flat or there is some degrowth happening. But overall, at a portfolio level, the percentage of revenues from OEMs definitely has grown as compared to Tier 1s.
Understood. And just one last question on my side. Can I get a little more details on the time line for the -- for the large deal that we won this quarter? When do we start expecting it to contribute to revenues, and how long is the deal flow?
It's a 5-year deal and the ramp-ups would start maybe middle of this quarter in a small way, but the major ramp-ups will start from January onwards.
The next question is from the line of Bhavik Mehta from JPMorgan.
Can you comment on the demand trends you're seeing in the Media and Communications side because this vertical has been weak for quite a long time now. Are there any signs of this bottoming out at all? Or do you think this headwinds can continue for the next couple of quarters as well?
Yes. It is -- frankly, the Media and Communications is a bloodbath. You look at any company in this area, you look at any competition, you look at overseas companies, everybody is -- I mean, all of us are seeing this tightening of budgets, and huge amount of consolidations happening in this industry vertical, lot of cost takeouts. The deals are primarily around cost takeouts and consolidations and so on. So I think while we are still staying afloat and what we're trying to do is to really use -- we have invested in a set of products and solutions and IPs. We really pushing some of those forward and really going to customers and saying that, hey, we can do things, what do you say, in a lot more efficient manner. We can help you take cost out. So those are the value proportions that we are taking to customers.
I think, definitely, the confidence is there in terms of growing, but whether the growth will be significant or not, I think it's very difficult at this point in time because most of the deals are -- comes with a huge amount of negotiation and cost takeout. So we will grow, but will it be a significant growth or not, very difficult to say at this point in time over the next couple of quarters, H2.
Okay. Got it. And lastly, on the margin side, I think last time there was a target of maintaining the margins at FY '24 level. So does that target still remain? Or will it come down given where 2Q has ended up?
No. I think we continue to target our margin in those expected band that we had communicated earlier also. Of course, there would be one-off blips here and there. This quarter, there was a salary increase done for the junior to mid. But with the H2, we believe to be a better half for us compared to the H1. So we believe that we can improve on the margins from here on.
The next question is from the line of Sulabh Govila from Morgan Stanley.
So my first question is on the transportation vertical. So just wanted to understand the large SDV deal that we had won in Asia, which is providing some growth in this particular quarter. Is this fully ramped up or it has tailwinds in the coming quarter as well?
Sulabh, I can take that. I think we have done a reasonable part of that ramp up, but we still have some room to go.
And that would be fully done in 3Q or that will be an increasing momentum?
I think it will kind of peter out in about 2 quarters. So we should be done largely in Q3 with some amount of lift further in Q4.
Okay. Okay. Understood. And with respect to the Healthcare vertical, I understood that we mentioned that it has sort of bottomed out. But just wanted to understand, in this key customer where we were trying for renewals and new project starts, so do we now have the green light for these renewals and project starts or that is still pending?
We will have some partial restart this quarter. So to that extent, we have seen some visibility. And we hope by Q4, we will have -- we'll be back to the full plan.
Okay. Okay. So does that mean that whatever revenue decline we've seen in the past 2 quarters, that will fully come back in a couple of quarters? Or...
That is the focus and that is the intent that we have.
Okay. Okay. Understood. And the last bit is the -- on this media and telecom side, a new program that you launched on the -- taking the capability from media site to telecom on this RDK broadband implementation. So just wanted to understand how big you think this opportunity is for you can become as a percentage of revenue or of this vertical as a whole? How should one think about that?
Yes. Maybe I can take that. I think we see it in 2 contexts. One is that telcos have typically stayed shy of broadband and so on. And there have been -- only options have been either certain open standards or very proprietary devices that come from incumbent device suppliers that telcos had to adopt. I think for the first time, this offers a clear path where there's an open standard, there is global adoption and somebody like a Qualcomm backing it up. We are going to see significant movement of operators to adopt this kind of technology, but you have to understand, this is all going to be CapEx linked. So to that extent, I think you will see it play out over the next 2 years, right, so to be clear.
I think the big opportunity for us is not only to support that adoption and I think the biggest gain for us would be really our entry into telcos using this bench. So in that sense, for us, it's a very strategic long-term play rather than anything that we see in the very short term.
Okay. Understood. And is there a particular billing model or monetization in this, which is involved? How should one think about that?
No. At this time, it is still clear product engineering, right? So there is no fancy model that comes in.
Yes. It will be outcome-based or it would be time material, it's a standard model.
The next question is from the line of Kamlesh Kumar, who is an Individual Investor.
Am I audible?
Yes, Kamlesh, go ahead.
First of all, I convey my condolences on Mr. Ratan Tata demise. It is a loss for not only Tata Elxsi, Tata group companies, the entire Indian population, such a great leader. Okay. Coming back to the question. I was just going through the presentation, I saw that there's major revenue coming from Europe and U.S., which is close to 70%. And considering the job loss data, which is released today, the job loss claim data, which is released today, there is an increase of around 200,000. So do you foresee any impact due to any slowdown in Europe or America on Tata Elxsi outcome in Q3 and Q4?
Maybe I can take that. I think typically, we are dependent. And if you understand our company profile, I think we excel in offshore delivery. So to that extent, we typically engage with customers with the promise of fantastic engineering delivered with talent that can scale from India. So -- and our on-site revenues are fairly minimal, and they're predominantly driven to support projects that we already won because the model of delivery also is a little bit of ownership driven. So to that extent, Europe and U.S. job loss data does not have as much of a consequence. It should be a bit of a tailwind because that means that there are more jobs coming our way.
The next question is from the line of [ Rajesh from Zenith ].
Am I audible, please?
Yes. Please go ahead.
Congratulations for a good set of numbers in this challenging environment, and I must appreciate and thank all the management team over here for the continuous effort. My question would be like, do you foresee any opportunities in the defense and semiconductor sector? And do we have the capabilities or do we -- or in case not, are we trying to build any capabilities in that area?
Yes. I think both defense and the semiconductor industry is of interest to us. So we've been working with the various DRDO labs and ISRO and the defense establishments on projects from time to time. Given the focus of the Indian government in a lot of new projects, especially in the defense from India and India based companies and so on. So we believe it's a good opportunity, especially with the capabilities that we have in imaging, in hardware designs, in the wireless technologies. There are a lot of things that can -- most of the defense is, what do you say, electronics that come out are a combination of many of these technologies. So we are actively looking at opportunities that come this way. And I think that is definitely an area of focus for us.
Similarly on the semiconductor side, there's a lot of investments coming in fabs and foundries and so that is another area we would definitely look at to see -- where we are engaged -- currently, we are engaged primarily in helping semiconductor companies more on the software application side. But having said that, that is an opportunity for us to really look at chip design. I mean, for many years, we've had that semiconductor. We had a unit that usually -- that focused on chip design, and we've actually taped out chips SoCs for our customers, right, maybe 10 years ago. So definitely, that's -- we know the domain. We know the field. Definitely an opportunity for us to really get back and see what sort of investments we should be making in rebuilding some of the capabilities that we've sort of let go right at that point in time. So yes, I think both of these are of interest to us.
Because the opportunity size is very huge, I think, as I understand.
Yes, it is. I mean each of these come with their own complications, right? It's -- and these are really high-tech areas, right? They're not run-of-the-mill projects and so on. So we really need to have that capability to really enter the field and stay in the field, right? So that's something that we are evaluating from a future perspective.
The next question is from the line of [ Harshal Sheth ], who is an Individual Investor.
As there is no response from the line of current participant, we'll move on to the next question. Next question is from the line of Vinesh Vala from HDFC Securities.
I just had one clarity that you told that we are bottoming out in healthcare in Q3, and our pipeline remains strong. So what's the overall view on that?
Sorry, your voice was sort of echoing. What was the question once again?
So if I heard it right, you told that we have bottomed out in Q3, expecting to bottom out in Q3 for the healthcare vertical. Am I right?
Yes. That's correct.
Okay. Sir, another question I was having that as you told that your OEMs are going faster than Tier 1. So what would be the percentage of OEMs of the total transportation?
Today, I mean, this quarter, we have touched 68% from an OEMs perspective of our overall transportation revenue.
Okay. So it's 68%. And we expect that to go ahead?
Some of the large deals that we have won are all OEM deals. So yes, over a period of time, yes, next couple of quarters, we expect naturally the OEM business to grow.
And just Vinesh, the bottoming out was referring to Q2, not Q3. Just to clarify for healthcare.
The next question is from the line of Niket from MO Asset Management Company.
Just 2 questions. One, if you can just give some color on how the JLR ramp-up has been happening? And what do you expect for the H2 of this year?
JLR has been a steady customer of ours and a lot of new edge capabilities that they have built essentially based on the work that we have been doing with JLR, including software-defined vehicles and the complete EV, the powertrain area. We are very, very strong lock-in with JLR, right? So that's been a fantastic journey for us. Having said that, we all know JLR is also going through its own issues. Their sales are going down. So while JLR continues to be an important customer, we definitely have built other OEM customers. And the H2 growth for us will definitely come. Of course, JLR will continue to grow, but there will be faster growth in other OEMs.
Got it. Got it. And the second question was if you look at the business model of Tata Elxsi, obviously, auto has been a consistent growth driver for you with a bit of volatility on Healthcare and Media and Entertainment. Do you think that while these are 3 major verticals that you continue to run, of which 2 continue to remain fairly volatile. You would need 1 or 2 new verticals to come and ensure that the growth is much more, I would say, structural rather than a bit cyclical at least on a couple of those segments that I mentioned about. So how would you look at newer verticals being added or any M&A kind of opportunity within the existing verticals to ensure that the growth is slightly more higher than what you are currently at?
No. I agree. I mean it's not as if transportation was always firing, right? During COVID, if you look at it, Transportation segment actually went down and it was the Media and Communications and Healthcare that actually grew at that point in time. So I think we are very much aware, but I think that is also the strength of this sort of 3 verticals that we have, right? They're sort of orthogonal and -- so having said that, we are looking at newer areas, newer industry verticals to get in. There are many options that we have been evaluating. So yes, I think, hopefully, from our next financial year strategy perspective, definitely, there's a focus in building newer verticals. We will announce that at the appropriate time.
The next question is from the line of Manik Taneja from Axis Capital.
My apologies, I joined the call late. I actually wanted your inputs on a couple of things. Number one thing is we've seen headcount come off in the current quarter. If I recall correctly, last quarter, while you've been talking about project investments from a headcount standpoint this year, but you have been talking about hiring pressures in the current quarter and thereby expect the head count to go up. If you could talk about the plan on that front?
And also, with regards to JLR, if I go to your annual report, the approval that one has taken in terms of related party transaction limit that suggests that JLR will essentially grow in excess of 50% this year. Are we on track with some of the challenges that you spoke about in case of JLR in the near term? And also, how should we be thinking about the ramp up on the auto OEM deals given the way headcount actually has been trending.
Yes. So coming to your fresher -- the question regarding freshers, no, we have not added any freshers in this quarter and in Q2. The fresher addition will happen in Q3, right? So that is about the freshers. From a JLR perspective, what we have taken the omnibus approval that we have taken is INR 1,000 crores. That is really -- we looked at it from a 2-year perspective, right so that we don't need to go again and again to the investors for approval. The intent was never to say that okay, JLR will be INR 1,000 crores in this financial year. So I think the JLR has been growing pretty well for us. But still there's a long way to go to achieve INR 1,000 crore number that you're talking. That will be a good target for us eventually. Was there any other question?
Sir, my question was with regards to how should be thinking about the growth trajectory given that headcount has been coming off in the last couple of quarters? And the last question from my end. You had spoken about FY '25, you have better growth year than FY '24, when you announced your full year numbers. Clarification on that is, are we looking at this from a constant currency growth, rupee number, a dollar number because if I do some math the asking -- the ask rate for second half is extremely high price if I [ used ] this to be on constant currency model.
So I think we've discussed that in a previous question as well. Yes, so when we looked at end of Q1, we were pretty confident in terms of look being able to better our growth in the last financial year. However, with now H1 gone, while the intent is still there to see if we can get to a double-digit constant currency growth, I know the ask is huge. But the good part is that, look, we have won certain deals, and we'll have to ramp up them over the next half year. On top of it, there are other deals that we are bidding for, that also gives us a good feel that, look, it is possible. Having said that, I know it's an extremely difficult task. But we don't want to change our goals, right, short-term goals now. We will take a look at it at the end of Q3 and see where we stand.
So Manoj, I know I'm pushing you, but given the speed of news flow from global auto OEMs in the recent months, and each of them essentially are seeing their own specific volume-related challenges or offtake on the EV side, do you think given the tailwinds that this industry segment has enjoyed in the last 3, 4 years, we could probably go through a phase of slow decision making and reprioritization at customer end and thereby some pressure for the auto R&D segment?
It is true. I think this question was also asked earlier. So it is true that the general auto industry is going through slowdown. EV sales are not picking up, all of that is true. But having said that, there are deals that we have already closed that ramp-ups are happening. So the confidence comes from the fact that, look, there is the visibility that we have. And we are also looking at new deals, if I look at the pipeline that we have. And the good part is some of these deals are not necessarily from U.S. or Europe OEMs, there are substantial deals in Asia and Japan and so on.
Where we see that, look, many of these -- some of these OEMs have been late to the party. And so they are in a hurry to catch up. So we would definitely see some of these deals closing. And again, we don't need 20 deals to close in our favor, right? All we need is 1 or 2 large deals every quarter. So I think we are there. We are seeing some of those deals. And even if the industry is going through a lot of turmoil and so on, all we need is those 1 or 2 deals that will really help us and keep us afloat.
[Operator Instructions] As there are no further questions, I would now like to hand the conference over to the management for closing comments.
Wonderful. Thank you so much for all the questions. We will get back again end of Q3. And hopefully, we will have a better growth story at that point in time. And thank you so much, and good night, good evening. Take care.
Thank you. On behalf of Tata Elxsi, that concludes this conference. Thank you for joining us. You may now disconnect your lines.